Kidney Week

Oral Abstract Session

Precision Medicine in Diabetic Kidney Disease: Biomarkers, Combination Therapies, and Treatment Response Prediction

November 06, 2025 | 04:30 PM - 06:00 PM

Location: Room 372A, Convention Center

Session Description

Oral Abstract Session

Note: Continuing education credits are not being offered for this session.

Learning Pathway(s)

• Diabetic Kidney Disease

Moderators

• Christos Argyropoulos, MD, MS, MSc, PhD, FASN
• Laura Pyle, MS, PhD

Presentations

• Trajectory from Glomerular Hyperfiltration to Rapid GFR Decline in Youth with Obesity and Type 2 Diabetes as They Transition to Young Adulthood
  04:30 PM - 04:40 PM
  
  • Phoom Narongkiatikhun, MD

Trajectory from Glomerular Hyperfiltration to Rapid GFR Decline in Youth with Obesity and Type 2 Diabetes as They Transition to Young Adulthood

November 06, 2025 | 04:30 PM - 04:40 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Glomerular Sieving Index: Novel Marker of Glomerular Permeability and Disease Progression in Diabetes
  04:40 PM - 04:50 PM
  
  • Aschariya Wipattanakitcharoen, MD

Glomerular Sieving Index: Novel Marker of Glomerular Permeability and Disease Progression in Diabetes

November 06, 2025 | 04:40 PM - 04:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Identifying Nonresponders to SGLT2 Inhibitors in the CREDENCE Trial: Biomarker-Guided Approach for Targeting Alternative Therapies
  04:50 PM - 05:00 PM
  
  • Sok Cin Tye, PhD

Identifying Nonresponders to SGLT2 Inhibitors in the CREDENCE Trial: Biomarker-Guided Approach for Targeting Alternative Therapies

November 06, 2025 | 04:50 PM - 05:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• SGLT2 Inhibitors Reverse Hypoxia-Inducible Factor (HIF)-1A Regulatory Network Activation in Diabetic Kidney Disease
  05:00 PM - 05:10 PM
  
  • Jennifer A. Schaub, MD

SGLT2 Inhibitors Reverse Hypoxia-Inducible Factor (HIF)-1A Regulatory Network Activation in Diabetic Kidney Disease

November 06, 2025 | 05:00 PM - 05:10 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Cardiovascular Risk Prediction Modelling with Sotagliflozin in Type 1 Diabetes: Analysis of inTandem 1-3 Trials
  05:10 PM - 05:20 PM
  
  • Vikas Sridhar, MD

Cardiovascular Risk Prediction Modelling with Sotagliflozin in Type 1 Diabetes: Analysis of inTandem 1-3 Trials

November 06, 2025 | 05:10 PM - 05:20 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Renal Functional Reserve Predicts GFR Response to Empagliflozin but Not Linagliptin or Sulfonylureas in Patients with Type 2 Diabetes
  05:20 PM - 05:30 PM
  
  • Marcel Muskiet, MD, PhD

Renal Functional Reserve Predicts GFR Response to Empagliflozin but Not Linagliptin or Sulfonylureas in Patients with Type 2 Diabetes

November 06, 2025 | 05:20 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Reproducibility of Placebo-Corrected Albuminuria Responses to Dapagliflozin in Type 2 Diabetes and CKD: Bayesian N-of-1 Trial Approach
  05:30 PM - 05:40 PM
  
  • Jelle Beernink, MD

Reproducibility of Placebo-Corrected Albuminuria Responses to Dapagliflozin in Type 2 Diabetes and CKD: Bayesian N-of-1 Trial Approach

November 06, 2025 | 05:30 PM - 05:40 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Dosing, Treatment Patterns, Urine Albumin-to-Creatinine Ratio (UACR) Changes, and Safety with Finerenone Treatment in Routine Care: FINE-REAL Interim Analysis
  05:40 PM - 05:50 PM
  
  • Ricardo Correa-Rotter, MD

Dosing, Treatment Patterns, Urine Albumin-to-Creatinine Ratio (UACR) Changes, and Safety with Finerenone Treatment in Routine Care: FINE-REAL Interim Analysis

November 06, 2025 | 05:40 PM - 05:50 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Potential of Triple Therapy in Diabetic Kidney Disease
  05:50 PM - 06:00 PM
  
  • Lean Alkhatib, MD

Potential of Triple Therapy in Diabetic Kidney Disease

November 06, 2025 | 05:50 PM - 06:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.